Companion Diagnostics (CDx) Development Services Market, by Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridisation, Immunohistochemistry (IHC), Digital Imaging, Brewin Based Assay), by Application (Oncology, Cardiology, Neurology, Autoimmune Diseases, Microbiology, Organ Transplantation) and, by End-user (Diagnostic Laboratories, Hospitals, Clinics, Academic and Research Institutes): Opportunity Analysis and Industry Forecast, 2023-2032

The Companion diagnostics (cdx) development services market is analyzed at a global, regional, and country levels providing analysis of different segments divided depending on its characteristics such as by Technology, by Application, by End-user.

Companion diagnostics (cdx) development services market Overview

The scope of the report focuses on the qualitative analysis covering drivers, opportunities, challenges, and trends. In addition, it emphasizes on the key strategies adopted by the players. Moreover, the major players operating in the market have been profiled in the report along with their strategic developments, including acquisitions, mergers, products launch, agreements, partnerships, collaborations, joint ventures, research & development investment, and regional expansion of leading companies operating in the market at global and regional levels.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers, And Impact Analysis

Increase/decline that is witnessed in the demand for Companion diagnostics (cdx) development services market has been analyzed in the study. In addition, the impact of cost on the market growth/decline has been studied and elaborated. Moreover, a cumulative effect of the potential factors are likely to expose a few niche market opportunities that can be capitalized by companies across the globe.

Key companies identified in the report include Roche Diagnostics, Illumina, Qiagen, Agilent Technologies, Eurofins Scientific, bioMérieux, Exact Sciences, Proteintech Group, PerkinElmer, Abbott Molecular

Key Reasons to Buy the Report

1. Major region/country level quantitative and qualitative analysis

2. Detailed segment analysis at country level

3. Key supplier profiling and market share analysis

Free 20% customization and post-sales support

  Companion Diagnostics Report Highlights

Aspects	Details
By Technology	Next Generation Sequencing Polymerase Chain Reaction In Situ Hybridisation Immunohistochemistry (IHC) Digital Imaging Brewin Based Assay
By Application	Oncology Cardiology Neurology Autoimmune Diseases Microbiology Organ Transplantation
By End-user	Diagnostic Laboratories Hospitals Clinics Academic and Research Institutes
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	bioMérieux, Eurofins Scientific, Illumina, Qiagen, Abbott Molecular, PerkinElmer, Roche Diagnostics, Agilent Technologies, Proteintech Group, Exact Sciences

^*Terms and Conditions Apply